AzTrials
AzTrials

Intensive Care Unit (ICU) AdmissionICUNCT06726733

Assessing Intensive Care Unit (ICU) Indications: Human vs. ChatGPT-4o Predictions

An observational study of Intensive Care Unit (ICU) Admission and Emergency Department Patient, run by Bursa Yuksek Ihtisas Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This retrospective study evaluates the accuracy of ICU admission indications by comparing clinical decisions with predictions from ChatGPT-4. Patient data, including demographics, vital signs, laboratory results, imaging findings, and clinical decisions, will be retrospectively collected and documented systematically… Read more about this study

Who is it for?
Ages 18 years and older
How many people
624 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2024to 28 Feb 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: 500

Who may be able to join

  • Patients aged 18 years and older who are consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department will be included in the study.

Who cannot join

  • Patients consulted to the anesthesiology and reanimation clinic for ICU indications from inpatient services.
  • Patients consulted to the anesthesiology and reanimation clinic from the emergency department for reasons other than ICU indications.
  • Patients consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department but with insufficient recorded data (patients with data loss)

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bursa Yuksek Ihtisas Training and Research Hospital

    Bursa

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Accuracy of Intensive Care Unit (ICU) Admission Indications in Emergency Department Patients: A Comparison Between Clinical Decisions and ChatGPT-4o Prediction

This retrospective study evaluates the accuracy of ICU admission indications by comparing clinical decisions with predictions from ChatGPT-4. Patient data, including demographics, vital signs, laboratory results, imaging findings, and clinical decisions, will be retrospectively collected and documented systematically using Case Report Forms. The model will be trained using ICU admission guidelines and tasked to predict ICU needs based on collected patient data. This study aims to systematically assess the alignment between AI-based predictions and clinical decisions for ICU admissions.

Read the detailed description

This study has a retrospective design. The medical data of patients admitted to the emergency department and consulted to the anesthesiology and reanimation clinic for ICU indications will be collected retrospectively. Demographic information, vital signs, laboratory results, imaging findings, and clinical decisions of the patients will be recorded. These data will be systematically collected for each patient using an individual Case Report Form.

Inclusion Criteria for the Study:

Patients aged 18 years and older who were consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department will be included in the study.

Exclusion Criteria for the Study:

Patients consulted to the anesthesiology and reanimation clinic for ICU indications from inpatient services.

Patients consulted to the anesthesiology and reanimation clinic from the emergency department for reasons other than ICU indications.

Patients consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department but with insufficient recorded data (patients with data loss).

Model Training and Prediction Analysis:

ChatGPT-4 will be trained according to the guidelines in "Yoğun Bakım Hasta Kabul Kriterleri (Rehberleri)" by Çiftçi B, Erdoğan C, and Demiraran Y (5). The collected patient data will be presented to the ChatGPT-4 model to obtain predictions regarding whether the patients require ICU admission. The predictions made by ChatGPT will be compared with clinical decisions, and accuracy rate, false positive rate, and false negative rate will be analyzed.

Statistical Analysis Methods to Be Used in the Study:

Accuracy Rate: The rate at which ChatGPT correctly predicts ICU indications will be calculated.

False Positive Rate: The rate at which ChatGPT predicts ICU need for patients who do not require ICU admission will be evaluated.

False Negative Rate: The rate at which ChatGPT predicts no ICU need for patients who require ICU admission will be analyzed.

Kappa Statistics: The agreement between ChatGPT predictions and clinical decisions will be measured.

ROC Curve and AUC: The performance of ChatGPT will be evaluated using the ROC curve and AUC.

The Case Report Form used for each patient ensures detailed and systematic data collection of clinical information, aiming to meaningfully compare the alignment of ChatGPT's predictions with clinical decisions.

Keywords
AI, Intensive Care Unit, Clinical decision-making, Artificial Intelligenc

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy rate of ChatGPT-4 in predicting ICU indications

    Measured: 3 month

  2. False positive rate

    Measured: 3 month

  3. False negative rate

    Measured: 3 month

Secondary outcomes (1)
  1. Kappa statistic

    Measured: 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2024
  2. Study start1 Sep 2024
  3. Primary completion30 Nov 2024
  4. Study completion28 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
624 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06726733
Sponsor's protocol ID
BYIEAH-INKA
Acronym
ICU
Status last verified
Apr 2026
First submitted
6 Dec 2024
Last updated
14 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intensive Care Unit (ICU) Admission and Emergency Department Patient, run by Bursa Yuksek Ihtisas Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy rate of ChatGPT-4 in predicting ICU indications (time frame: 3 month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in